Detalhe da pesquisa
1.
MicroRNAs as a clue to overcome breast cancer treatment resistance.
Cancer Metastasis Rev
; 41(1): 77-105, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34524579
2.
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer.
Int J Mol Sci
; 24(4)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835014
3.
Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines.
Int J Mol Sci
; 25(1)2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203378
4.
KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
PLoS Pathog
; 16(10): e1009006, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33057440
5.
Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
Curr Oncol Rep
; 24(10): 1337-1349, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35648340
6.
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.
Int J Mol Sci
; 23(21)2022 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362083
7.
Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer.
Int J Mol Sci
; 22(24)2021 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34948097
8.
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective.
Int J Mol Sci
; 22(15)2021 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360578
9.
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Int J Mol Sci
; 21(19)2020 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33050096
10.
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.
Br J Cancer
; 115(3): 322-31, 2016 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27404455
11.
The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.
Int J Mol Sci
; 17(8)2016 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27517917
12.
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
J Cell Biochem
; 116(9): 2061-73, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25802200
13.
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.
Cancer Cell
; 11(3): 245-58, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17349582
14.
Oxidative stress in susceptibility to breast cancer: study in Spanish population.
BMC Cancer
; 14: 861, 2014 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25416100
15.
MicroRNA profile in very young women with breast cancer.
BMC Cancer
; 14: 529, 2014 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25047087
16.
Emerging EGFR antagonists for breast cancer.
Expert Opin Emerg Drugs
; 19(2): 165-81, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24831079
17.
Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival.
Mol Cell Biochem
; 379(1-2): 181-90, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716179
18.
Synthesis of 2-aminopropyl benzopyran derivatives as potential agents against triple-negative breast cancer.
RSC Med Chem
; 14(11): 2327-2341, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020071
19.
Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy.
ACS Appl Mater Interfaces
; 15(32): 38323-38334, 2023 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549382
20.
Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies.
Cancers (Basel)
; 15(18)2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760491